International Headache Society Committee on Clinical Trials in Migraine.
Guidelines for controlled trials of drugs in migraine. First edition.
Cephalalgia1991;
11:
1–12.
2.
CutlerNMushetGRClementsBWhitcherL.Oral sumatriptan for the acute treatment of migraine: evaluation of three dosage strengths.
Neurology1995;
45Suppl 7:
S5–S9.
3.
SargentJKirchnerJRDavisRKirkhartB.Oral sumatriptan is effective and well tolerated for the acute migraine: results of a multicenter study.
Neurology1995;
45Suppl 7:
S10–14.
4.
RapoportAMRamadanNMAdelmanJUMathewNTElkindAHKudrowDBon behalf of the 017 Clinical Trial Study Group. Optimizing the dose of zolmitriptan (Zomig, ∗311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study.
Neurology1997;
49:
1210–8.
5.
GijsmanHKramerMSSargentJTuchmanMMatzura-WolfeD.Double-blind, placebo-controlled, dose-finding study of rizatriptan (MK-462) in the acute treatment of migraine.
Cephalalgia1997;
17:
647–51.
6.
KlassenAElkindAAsgharnejadMWebsterCLaurenza A, on behalf of the Naratriptan S2WA3001 Study GroupNaratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, parallel-group study.
Headache1997;
37:
640–5.
7.
MathewNTAsgharnejadMPeykamianMLaurenza A, on behalf of the Naratriptan S2WA3003 Study Group.Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, crossover study.
Neurology1997;
49:
1485–90.
